Groisy, France

Vincent Pomel

USPTO Granted Patents = 22 

 

 

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2006-2022

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):

Title: Innovations and Contributions of Vincent Pomel in Pharmaceutical Patents

Introduction

Vincent Pomel, an inventive force based in Groisy, France, has made significant contributions to the field of pharmaceuticals, securing an impressive portfolio of 22 patents. His work focuses on innovative compounds that provide therapeutic solutions for various medical conditions, showcasing his dedication to advancing healthcare through innovative inventions.

Latest Patents

Vincent's recent patents include groundbreaking formulations such as the alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and its salt form, as well as its crystal polymorphs. These compounds are designed to inhibit the prostaglandin F receptor, which is crucial in treating disorders like preterm labor at the early gestational stage. Additionally, he introduced pharmaceutical compositions that combine these compounds with additional therapeutic agents, thereby enhancing their efficacy and utility in clinical settings.

Career Highlights

Throughout his career, Vincent has collaborated with esteemed organizations in the pharmaceutical industry, including Merck Serono S.A. and Applied Research Systems Ars Holding N.V. His experiences in these companies have helped him refine his innovative approaches and establish a robust understanding of drug development. His work not only contributes to his personal accolades but also significantly impacts the pharmaceutical landscape.

Collaborations

Vincent Pomel has worked alongside notable colleagues, such as Anna Quattropani and Matthias Schwarz. These collaborations have fostered a rich exchange of ideas and expertise, further driving the innovation of therapeutic agents that address critical healthcare needs.

Conclusion

Vincent Pomel exemplifies the spirit of innovation within the pharmaceutical field. Through his 22 patents and commitment to research and development, he continues to impact patient care positively. His latest contributions, aimed at treating serious medical conditions, enhance our understanding of effective therapies and exemplify the importance of collaboration in the realm of scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…